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Abstract
Background: Older adults can benefit from physical activity in numerous ways. Physical activity is considered to be
one of the few ways to influence the level of frailty. Standardized exercise programs do not necessarily lead to
more physical activity in daily life, however, and a more personalized approach seems appropriate. The main
objective of this study is to investigate whether a focused, problem-oriented coaching intervention (‘Coach2Move’)
delivered by a physiotherapist specializing in geriatrics is more effective for improving physical activity, mobility and
health status in community-dwelling older adults than usual physiotherapy care. In addition, cost-effectiveness will
be determined.
Methods/Design: The design of this study is a single-blind randomized controlled trial in thirteen physiotherapy
practices. Randomization will take place at the individual patient level. The study population consists of older adults,
≥70 years of age, with decreased physical functioning and mobility and/or a physically inactive lifestyle. The
intervention group will receive geriatric physiotherapy according to the Coach2Move strategy. The control group
will receive the usual physiotherapy care. Measurements will be performed by research assistants not aware of
group assignment. The results will be evaluated on the amount of physical activity (LASA Physical Activity
Questionnaire), mobility (modified ‘get up and go’ test, walking speed and six-minute walking test), quality of life
(SF-36), degree of frailty (Evaluative Frailty Index for Physical Activity), fatigue (NRS-fatigue), perceived effect (Global
Perceived Effect and Patient Specific Complaints questionnaire) and health care costs.
Discussion: Most studies on the effect of exercise or physical activity consist of standardized programs. In this
study, a personalized approach is evaluated within a group of frail older adults, many of whom suffer from multiple
and complex diseases and problems. A complicating factor in evaluating a new approach is that it may not be
automatically adopted by clinicians. Specific actions are undertaken to optimize implementation of the
Coach2Move strategy during the trial. Whether or not these will be sufficient is a matter we will consider
subsequently, using quality indicators and process analysis.
Trial Registration: The Netherlands National Trial Register: NTR3527.
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Background
Physical activity is considered one of the few ways to in-
fluence frailty in older adults [1-4]. The extent to which
the level of frailty can be influenced by physical activity
remains unclear, however. Frailty is defined as a complex
state of increased vulnerability to adverse health out-
comes [5]. The causes as well as the consequences of
frailty are diverse and originate from multiple dimen-
sions (physical, psychological and social), which makes
frailty a difficult concept to measure [6]. A small number
of studies have shown a positive effect of physical activ-
ity on the level of frailty by measuring physical aspects
of frailty [7,8]. The positive effect of exercise on other
frailty-related aspects of health, for example, mood and
cognition, has also been confirmed in studies [9,10]. The
complex interaction between the physical, psychological
and social dimensions of frailty influences the level of
frailty. The total level of frailty is, therefore, not equiva-
lent to the sum of its components. When, for example,
muscle strength improves because of an exercise inter-
vention, this could lead to better mobility and the ability
to become more physically active. Also, it may become
easier to go outdoors, which can positively influence
mood and social interaction. As a consequence, when all
these dimensions are taken into account, the level of
frailty may improve by even more than the levels of the
separate components. The multidimensional level of
frailty, considering all aspects of frailty in interaction
using one measurement instrument, has not been evalu-
ated in intervention studies on exercise and physical ac-
tivity hitherto.
Furthermore, while the positive effect of physical activ-
ity on different aspects of health is widely accepted,
many older adults remain sedentary [11]. Standardized
supervised exercise interventions do not necessarily in-
crease the level of physical activity in daily life [12]. It is
a great challenge to attain the behavioral change that is
necessary to become more physically active in the long
term and to improve adherence to physical activity pro-
grams or interventions. Individually adapted programs
that aim for participants to become more physically ac-
tive in daily life are probably more (cost-) effective [13].
We have developed an individual intervention aimed at
promoting physical activity in the broad population of
older adults suffering from or at risk of mobility prob-
lems. Most older adults have to deal with multiple and
complex problems and diseases, and yet often they do
not fulfil the specific inclusion criteria used in clinical
studies. Therefore, we developed an intervention aimed
at a very broad population of older adults. Because of
the complexity of this intervention, the Medical Re-
search Council (MRC) framework was used as a guide in
developing the intervention. The MRC framework con-
sists of five successive phases: preclinical or theoretical
phase (phase I), modelling phase (phase II), exploratory
trial (phase III), randomized controlled trial (phase IV),
and long-term implementation (phase V). In the theoret-
ical phase, we performed two systematic reviews. The
first review deals with instruments for measurement of
frailty. In this review, we concluded that numerous
measurement instruments exist, but none of them has
been developed as an outcome measure [6]. Therefore,
we subsequently developed an outcome instrument on
frailty; the Evaluative Frailty Index for Physical Activity
(EFIP) [14]. In a second article, we review the literature
on the effect of physical exercise therapy in older adults
who have problems with physical functioning and/or
have to deal with co-morbidity [12]. The included litera-
ture was evaluated in meta-analyses and we concluded
that mobility and physical functioning are positively in-
fluenced by physical exercise therapy. Strength training
also seemed to be of great importance and a personal-
ized approach may result in long-term positive effects
(>12 months). No positive effects on quality of life and
the level of physical activity could be found, which con-
firms that an exercise intervention does not necessarily
bring about changes in level of physical activity.
In the modelling phase of the MRC framework, we devel-
oped the intervention based on the findings from the theor-
etical phase and expert consultation. This process will be
described in detail in another publication. The intervention
was called ‘Coach2Move’ and is based on clinical reasoning
conforming with the Hypothesis Oriented Algorithm for
Clinicians (HOAC)-II [15,16] and the International Classifi-
cation of Functioning, Disability and Health (ICF) [17]. The
HOAC-II is an algorithm for clinical reasoning that de-
scribes all steps to be taken in order to make appropriate
decisions about the treatment of patients. The steps of the
HOAC-II were specified for the physiotherapy treatment of
frail older adults with mobility problems in the Coach2-
Move strategy. The core elements of the Coach2Move
strategy are: 1) increasing the level of physical activity and
(social) participation; 2) patient-identified goals, and
thereby improving adherence; 3) enablement instead of dis-
ablement (what a patient can do instead of what a patient
cannot do); and 4) self-management. The Coach2Move
strategy was tested for feasibility and efficacy in a pilot
study (NM De Vries et al., unpublished observations). The
results of this pilot study showed that the Coach2Move
strategy is well appreciated by both physiotherapists and
patients and that a positive effect on physical activity, mo-
bility, frailty and quality of life can be expected. The present
article describes the study design of a Randomized Con-
trolled Trial (RCT) to evaluate the Coach2Move strategy.
The main objective of this RCT is to test the hypothesis
that the Coach2Move strategy delivered by a physiotherap-
ist specializing in geriatrics is more effective in improving
physical activity in community-dwelling older adults than is
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usual physiotherapy care. As a secondary objective, the ef-
fect of the Coach2Move strategy on the (multidimensional)
level of frailty, mobility and quality of life, as well as cost-
effectiveness, will be assessed in comparison with usual
physiotherapy.
Methods/Design
Study design
The study design is a single-blinded randomized con-
trolled trial (RCT) in which the consort guidelines are
being followed. The RCT is being performed in thirteen
physiotherapy practices. In each participating practice
both a general physiotherapist (PT) and a PT specializing
in geriatrics (GPT) will participate in the study. Partici-
pating GPTs will be trained in the Coach2Move strategy.
The PTs will provide the usual care.
Participants
The population consists of (pre-)frail older adults with mo-
bility problems and/or a physically inactive lifestyle who are
at risk of loss of mobility in the near future. This study fo-
cuses on elderly people living relatively independently at
home or in a home for elderly people. Older adults with
acute health problems for which hospital admission or ad-
mission to a nursing home is necessary are excluded. Older
adults signed up for physiotherapy are considered for inclu-
sion, whether referred by a physician or having decided to
attend physiotherapy by themselves.
The inclusion criteria are as follows:
1. Older adults aged ≥ 70 years living independently at
home or in an older persons’ home.
2. A mobility problem and/or a physically inactive
lifestyle (< 30 minutes per day) rated as such by the
participant, their relatives or the referring physician.
The exclusion criteria are as follows:
1. Unable to walk 5 meters (waling aid allowed).
2. Unable to follow verbal or written instructions,
operationalized by a minimum score of 21 points on
the Minimal Mental State Examination (MMSE), or
unable to understand Dutch.
3. Palliative phase of illness.
4. Acute illness with hospital indication.
5. Severe degenerative neurological illness.
6. Having a contraindication for being physically active.
7. Having had physiotherapy for a period longer than
four weeks during the last six months.
Randomization, blinding and treatment allocation
All older adults (≥70 years old) who sign up for physiother-
apy in one of the participating physiotherapy practices, be-
cause of mobility problems and/or physical inactivity are
asked to participate in the trial by either a physiotherapist
or a practice secretary. If willing to participate, they are
called by a member of the research team within two days.
The member of the research team will determine potential
eligibility by telephone and make an appointment for base-
line measurement. An informed consent form is signed by
both the participant and the research assistant before the
baseline measurement. The final decision on inclusion or
exclusion and randomization takes place after baseline
measurement. Randomization is done on the individual
level through a computer-generated random-sequence
table. Pre-stratification is applied by physiotherapy practice.
Opaque, sequentially numbered, sealed envelopes are pre-
pared for each stratum (that is, physiotherapy practice) by a
researcher who is not involved in enrolling the participants,
in assigning them to their groups or performing follow-up
measurements. Each of the envelopes contains a sheet of
paper indicating one of the two interventions. The sealed
envelopes are delivered to the participating physiotherapists
or practice secretaries after baseline measurement. Partici-
pants learn their group assignments after the researcher or
research assistant involved in the baseline measurement
has left. Follow-up measurement at three and six months is
performed by two research assistants who are unaware of
group allocation.
Informed consent and ethical approval
All eligible patients are informed about this study and
given the time they needed to consider participation.
The investigator of this study and an independent phys-
ician not involved in the study may be approached for
questions. Patients who are willing to participate sign an
informed consent form. This study has been approved
by the medical ethical review board of the Radboud Uni-
versity Medical Centre, Nijmegen (registration number:
2012/233), and is registered in The Netherlands National
Trial Register (registration number: NTR3527).
Intervention
The intervention consists of geriatric physiotherapy accord-
ing to the Coach2Move strategy ([see Additional file 1 and
Table 1]). The Coach2Move strategy helps the GPT in clin-
ical reasoning by providing an extensive, pre-structured
and systematically organized diagnostic protocol. For the
diagnostic phase of the Coach2Move strategy more time
(1.5 hours) is available than for the conventional physio-
therapy intake (30 minutes). Impairments and disabilities,
but also possibilities, wishes, barriers and facilitators rele-
vant to physical functioning are thoroughly examined. Mo-
tivational interviewing is used to find and deal with the
barriers to individuals becoming physically active, but also
to find out what personal goals a patient wants to achieve.
Physiotherapy treatment in the Coach2Move strategy is fo-
cused on increasing motivation to be physically active by
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working on personal goals and removing physical barriers.
Using shared decision making together with the patient,
the GPT sets SMART goals – specific, measurable, accept-
able, realistic and (with a) timeline. The GPT coaches the
patient in reaching and maintaining his/her own goals (self-
management) using appropriate feedback.
In Coach2Move, three intervention profiles with a prede-
fined number of sessions can be chosen. Patients are cate-
gorized into one of these three profiles based on the
complexity of their problems and their potential for im-
provement. The first profile deals with patients who do not
need physiotherapy intervention on the level of body func-
tion or structure, but who just need coaching and advice
(≤4 sessions). The second profile is aimed at improving
functions, abilities and activities over a course of seven to
nine sessions for patients who need temporary treatment to
overcome barriers to becoming physically active. In the
third profile, patients with specific problems in participa-
tion, activities and functions are treated and coached in 12
to 18 sessions.
GPTs are trained in the Coach2Move strategy in a
basic training of two days. This training focuses on:–
1. Clinical reasoning.
2. Using appropriate measurement instruments in the
diagnostic phase but also in the evaluation of the
intervention and as feedback instrument for the
patient and therapist.
3. Shared decision making.
4. SMART focused goals (specific, measurable,
acceptable, realistic, timeline).
5. Learning to focus on coaching and self-management.
6. Learning to work in a patient-centered way and
using measurements for feedback.
7. Learning motivational interviewing skills.
8. Learning skills for adequate coordination with other
formal and informal caregivers involved.
In this study, the control intervention consists of conven-
tional physiotherapy provided by a PT. A one-day basic
training is organized for the PTs to enhance their motiv-
ation to participate in this RCT. The training consists of
general information regarding the treatment of older adults.
In this training, no attention is paid to clinical reasoning,
measurement instruments, shared decision making, motiv-
ational interviewing or self-management.
The treatment delivered by both the GPTs and the
PTs consists of conventional physiotherapy modalities
such as training activities in daily living, balance and
muscle strength. No standardized intervention is pre-
scribed and in both groups the physiotherapist is free to
determine the appropriate intervention and level to
reach the intervention goals. We expect less focus on
physical activity in the control group. Moreover, the
control group can freely decide how many sessions are
needed. This is standard procedure in physiotherapy
care in the Netherlands.
The key elements of the Coach2Move strategy are set
out in Table 1 and these are the main distinguishing fac-
tors between the intervention and the control group.
Even though shared decision making, patient-centered
treatment and goal setting on participation level are con-
sidered important, physiotherapists have difficulty actu-
ally applying this in clinical practice [18-20]. The
Coach2Move strategy offers education in these elements
and supports physiotherapists during the implementa-
tion, which we expect to result in a contrast between the
intervention and control groups. Both therapies are ex-
pected to be effective; however, we hypothesize that the
Coach2Move strategy will be more effective on the level
of physical activity and in reaching treatment goals in
fewer physiotherapy sessions.
Study parameters
The main study parameter is the level of physical activity
during follow-up over six months. The level of physical
activity will be measured using the LASA Physical Activ-
ity Questionnaire (LAPAQ) [21]. The LAPAQ is a reli-
able and valid instrument specifically developed for
older adults. The LAPAQ is a comprehensive question-
naire on diverse (physical) activities of daily living in-
cluding walking, riding a bicycle, gardening, light
household chores, heavy household chores and sporting
activities. Based on the results of this questionnaire, the
average amount of physical activity in minutes per day
and minutes per week can be assessed.
Secondary study parameters include mobility, quality
of life, level of frailty, fatigue and perceived effect. Mo-
bility is measured using the ‘get up and go’ test (GUG)
[22], the six-minute walking test (6MWT) [23] and walk-
ing speed (WS) timed over a 10-meter distance [24].
During the modified GUG, the patient is instructed to
Table 1 The innovative elements of the Coach2Move
strategy
The innovative elements of the Coach2Move strategy
1 Use of motivational interviewing: exploring questions for help and
barriers and facilitators in relation to physical activity.
2 Use of an algorithm (HOAC-II*a) that emphasizes an extensive intake
and supports clinical reasoning in order to set priorities.
3 Shared decision making on meaningful treatment goals to increase
physical activity.
4 Coaching on self-management to increase long-term results.
5 Focusing on meaningful activities at home with help from family,
friends or professionals.
6 Working according to three patient-tailored intervention profiles with
a predefined number of sessions.
aHOAC, Hypothesis Oriented Algorithm for Clinicians.
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rise out of a chair and walk 10 meters [24]. This proced-
ure is timed and the duration in seconds is the score for
this test. The effort of completing the same test is mea-
sured using the BORG scale of perceived exertion [25].
The Borg scale ranges from 6 to 20, where 6 indicates
no exertion and 20 the highest possible exertion. The
6MWT consists of six minutes walking at the patients’
self-determined pace. The score on this test is the dis-
tance in meters covered in six minutes. WS is timed on
a 10-meter distance. The mean time in seconds it takes
the patient to walk this distance (at his/her own pre-
ferred speed) over three tries, is the final score on this
test [24]. The SF-36 is used as a measure of quality of
life [26]. The SF-36 is a 36-item questionnaire on health
status. Questions relate to eight domains: vitality, phys-
ical functioning, bodily pain, general health perceptions,
physical role functioning, emotional role functioning, so-
cial role functioning and mental health. Each domain is
equally weighted and a standardized scoring system re-
sults in two scores: a physical score and a mental/emo-
tional score. Both scores range from 0 to 100 with an
average score of 50, and a higher score indicating a bet-
ter quality of life.
To measure the level of frailty, the Evaluative Frailty
Index for Physical activity (EFIP) is used [14]. The EFIP
is a 50-item questionnaire based on deficit accumulation
(symptoms, signs, disabilities) in multiple domains
(physical, psychological, social and general health status).
The score on this questionnaire is expressed as the ratio
of deficits present to the total number of deficits consid-
ered. The score ranges from 0 to 1, with 0 indicating no
frailty and 1 indicating maximum frailty.
Fatigue is measured using the Numeric Rating Scale
(NRS)-fatigue [27], which is a scale from 0 to 10 in
which the patient can indicate what level of fatigue is ex-
perienced. A score of 0 represents no fatigue at all and a
score of 10 represents the most possible fatigue.
Perceived effect is measured with the PSC (patient
specific complaints) questionnaire and Global Perceived
Effect (GPE). The PSC is an instrument in which pa-
tients can determine three activities in which they ex-
perience the most trouble [28]. For each activity one can
judge the level of experienced trouble on a scale from 0
to 10 in which 0 indicates no trouble at all and 10 indi-
cates that the activity cannot be performed. The Global
Perceived Effect (GPE) [29] score is used to measure the
patient’s opinion about the effect of the intervention on
a nine-point scale ranging from very much improvement
to very much deterioration.
Co-morbidity is registered using the Cumulative Ill-
ness Rating Scale-Geriatrics (CIRS-G) [30]. The CIRS-G
in combination with registration of the physiotherapy
intervention during each session and registration of
health care utilization will be used to explore whether a
physiotherapy intervention is adjusted because of the
presence of co-morbidity, if the presence of co-
morbidity influences the effect of an intervention, and if
co-morbidity brings about interventions other than
physiotherapy.
Health care utilization is registered by means of a
questionnaire. The questionnaire considers the type and
number of medical consultations, medication use, hos-
pital stay, nursing home stay, use of residential facilities,
professional home care and the purchase of assistive de-
vices in the three months before the questionnaire is
taken.
All these measurements are performed at baseline, at
three months and at six months by research assistants
who are blind regarding the group allocation of individ-
ual patients. At the final measurement, patients will also
be asked about their adherence during the physiotherapy
process by means of a short questionnaire.
An influencing variable is the quality of the Coach2-
Move strategy as delivered by the participating GPTs.
Therefore, we will provide the GPTs with an electronic
patient file in which the clinical reasoning process is
supported. An independent researcher, not involved in
follow-up measurement (NV), will have access to the pa-
tient files of all participating GPTs and check the records
for consistency with the Coach2Move strategy. If the
Coach2Move strategy is not being sufficiently followed,
the GPT concerned will be coached by the independent
researcher in the implementation of the strategy for that
specific patient. We are also developing quality indica-
tors to research fidelity to the actual Coach2Move strat-
egy by the participating GPTs. PTs register their
physiotherapy process in the usual way and are not coa-
ched during the intervention. The patient files of the
PTs will be scored with the quality indicators at the end
of the trial to determine the amount of contrast between
the GPT and PT groups.
Patient flow
Figure 1 describes the patient flow. This RCT has an inclu-
sion period of 15 months and a follow-up of six months.
This means that the RCT will be completed in 21 months.
Patient recruitment started in September 2012 and will end
in November 2013.
Sample size
To calculate the sample size, we use the formula for an
ANCOVA, derived by Teerenstra et al., which states that
the sample size uncorrected for clustering and baseline
measurement has to be multiplied by two factors [31]. First,
a factor that accounts for the clustering: DE = (1 + (n-1)
*ICC), where n is the average number of patients per ther-
apist and ICC is the intra-cluster correlation of patients
within a therapist. Second, a factor that accounts for the
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adjustment for baseline: (1-r2) with r = r_c*(n*ICC/DE) +
r_s*((1-ICC)/DE), where r_c is the autocorrelation and r_s
is the autocorrelation of patients. The autocorrelation is the
correlation between the three-month measurement and
baseline measurement.
Uncorrected sample size
In our pilot study of ten patients treated by one of two ther-
apists, we found on log scale an increase of 1.21 from base-
line and a standard deviation of 1.0 (in the pre-intervention
scores). This corresponds to a 3.35 fold increase from base-
line scores on the untransformed LAPAQ scale. The con-
trol group in our study is comparable to the experimental
group in the study performed by Rubenstein et al., which
found a 20% increase from baseline (1.2-fold increase) [32].
Thus the intervention is estimated to be 3.35/1.2 = 2.8
times as effective as the control treatment. To account for
possible overestimation of the effect by the pilot study and
possible contamination, we assume that at least 60% of this
effect will be retained; that is, the intervention is at least
1.68 times as effective as the control. Then, the effect on
log scale is 0.5 (sd = 1.0 as above). The uncorrected sample
size to detect this difference with 80% at a significance level
of 0.05 is 64 patients per group.
Adjustment for baseline
From our pilot study we estimated a subject-
autocorrelation r_s = 0.73; therapist-autocorrelation could
not be estimated (too few therapists), but conservatively we
set it to be moderate r_c = 0.4. Then r = 0.6 and the correc-
tion for baseline adjustment is 1-(0.62) = 0.64.
Clustering
In our pilot study we found ICC = 0 and, conservatively
setting the ICC = 0.05, the correction for clustering is
1 + (n-1)*0.05. Allowing for maximal 20% dropout, the
Information on study and invitation to participate in the study to patients attending practice ≥ 70 years with mobility problem and/ or 
physically inactive lifestyle.  
Informed consent and baseline assessment (T0) by blinded researcher: demographic characteristics, 
LAPAQ, SF-36, modified GUG, WS, 6MWT, EFIP, PSC, NRS fatigue, CIRS-G, healthcare 
utilization.
Randomization
Coach2Move by GPT Usual physiotherapy by PT
3 months
6 months
Evaluative assessment (t1) by blinded researcher : LAPAQ, SF-36, GUG, WS, 
6MWT, EFIP, PSC, NRS fatigue, GPE and questionnaire health care 
consumption
Evaluative assessment (t2): LAPAQ, SF-36, modified GUG, WS, 6MWT, 
EFIP, PSC, NRS fatigue, GPE, questionnaire health care consumption and 
questionnaire on adherence
PT registration as usual of : 
frequency and duration of 
contacts, goals, intervention 
strategies and intervention 
results. 
Research team contacts all clients willing to participate. Eligibility is determined and, when eligible, an appointment for t0 is made.
Registration in an electronic 
patient file especially designed 
for the coach2move strategy
Figure 1 Patient flow. CIRS-G, cumulative illness rating scale for geriatrics; EFIP, evaluative frailty index for physical activity; GPE, global perceived
effect; GPT, geriatric physical therapist; LAPAQ, LASA physical activity questionnaire; modified GUG, modified get up & go test; NRS fatigue, nu-
meric rating scale fatigue, PSC, patient specific complaints; PT, physiotherapist; SF-36, short form 36; WS, walking speed; 6MWT, 6 minute
walking test.
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corrected sample size can be calculated with: 64*0.64*(1
+ (n-1)*0.05)* 1/(80%). Table 2 gives the sample sizes
when a different number of physiotherapy practices are
included. If each participating physiotherapist (2 per
practice, 13 practices = 26 physiotherapists, 12 physio-
therapists per group) were to treat 5 patients, a total
number of 130 patients would be included (65 patients
per group). This is more than the 62 patients per group
necessary according to the power calculation (see
Table 1). If each therapist were to treat four patients,
however, the power would not be reached. Therefore we
will include 65 patients per group (total = 130) in this
trial.
Statistical analysis
Descriptive statistics will be used to present group charac-
teristics on age, education, marital status, multi-morbidity,
level of frailty, number of post-operative patients, therapy
adherence and adverse effects. Any asymmetry between the
intervention and control group on these variables at base-
line will be statistically corrected. The effects of the inter-
vention are analyzed according to the intention-to-treat
principle. The analysis of the primary and secondary out-
come measures employed a linear mixed model to relate
the three- and six-month outcomes to the effect of the
treatment. Therapist is taken as a random effect in this
model to account for the clustering of patients with thera-
pists. Measurement (baseline, 3 months, 6 months) is in-
cluded as a random effect to account for correlation of
measurements over time. Because this analysis uses all
three measurements (baseline, 3 and 6 months), it will ac-
tually be more powerful than an ANCOVA analysis and the
power of the study will be more than 80%.
Economic evaluation
This study investigates the potential efficiency of the
Coach2Move strategy compared with usual physiother-
apy care in frail elderly patients attending physiotherapy
after referral by a physician or by self-referral. The eco-
nomic evaluation is based on the general principles of a
cost-utility analysis, applying a health care perspective.
Primary outcome measures for the economic evaluation
are: costs and quality adjusted life years (QALY) (SF-6D,
part of SF-36) [26]. The incremental cost-effectiveness
ratio (ICER) ‘cost per QALY gained’ will be computed
and uncertainty surrounding this ICER will be deter-
mined using a non-parametric bootstrap method. A
cost-effectiveness acceptability curve will be derived that
is able to evaluate efficiency by using different thresholds
(Willingness To Pay) for a QALY gained. The impact of
uncertainty surrounding deterministic parameters on the
ICER will be explored using one-way sensitivity analyses
on the range of extremes.
Cost analysis
The cost analysis measures on patient level, volumes of care
(consisting of the production factors: personnel, materials
and capacity in a prospective way using therapist scoring
sheets (CRFs)). Per arm full cost-prices will be determined
using standard unit cost-prices according to the Dutch
guidelines for costing research [33]. If for certain proce-
dures standard unit cost-prices are not available, real cost-
prices will be determined using activity based costing. This
approach applies to the health care production part of the
economic evaluation. Medical costs will be estimated using
a questionnaire on a three-months recall basis in line with
the follow-up pattern of the clinical trial [34,35]. Non-
health care costs, like productivity losses, seem irrelevant
for this population
Health status
To measure the quality of the health status of the pa-
tients the SF-36 will be used. The SF-36 is a widely used
measure of general health in clinical studies throughout
the world. It currently generates eight dimension scores
and two summary scores for physical and mental health.
The SF-6D [34] provides a means for using the SF-36 in
economic evaluation by estimating a preference-based
single index measure for health from these data using
general population values. The SF-6D allows the analyst
to obtain QALYs from the SF-36 for use in cost utility
analysis. Utilities will be collected alongside the clinical
trial as described earlier in the section ‘Design’. These
utilities will be transformed into QALYs using the tra-
pezium method.
Discussion
Strengths
This is one of the first RCTs to evaluate a systematic,
individually-tailored physiotherapy intervention for older
adults embedded in clinical practice. In most research,
standardized exercise programs are evaluated while in
daily clinical practice physiotherapy usually is a tailor-
made intervention. We expect a larger effect from a tai-
lored intervention than from a standardized exercise
Table 2 Sample size calculation
n = Number of
patients per cluster
Sample size per group:
64*0.64*(1 + (n-1)*0.05)*
1/(80%)
#Clusters group:
sample size /n
10 75 8
9 72 8
8 70 9
7 67 10
6 64 11
5 62 13
4 59 15
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program. In addition, most other studies aim at a spe-
cific population of older adults, for example, older adults
with diabetes or arthritis, excluding older adults with
multiple comorbidity. However, most older adults have
to deal with more than one health problem and do not
fulfil the inclusion criteria set in most studies on stan-
dardized exercise programs. The intervention studied in
this RCT is therefore more representative for clinical
practice than the interventions in previously performed
RCTs.
Weaknesses
Although we expect a large effect from an individually tai-
lored intervention, researching physiotherapy also brings
about some difficulties because of the variety in the inter-
vention. Every physiotherapist deals with patients in his or
her own way. Additionally, because we include a very broad
population of older adults in this RCT, there will be some
variety in the participants. Finally, implementing a new
treatment strategy like Coach2Move is a challenging
process. A new strategy is not automatically adopted by
healthcare professionals even after they have been trained in
that strategy. Various determinants either positively or nega-
tively influence the implementation process, for example,
the characteristics of the new strategy, characteristics of the
adopting person, characteristics of the organization or char-
acteristics of the socio-political context [36]. Also, healthcare
professionals are thought to go through four stages in an
implementation process. The first is the dissemination stage
in which the professional finds/is supplied with the new
strategy. The second is the adoption stage in which the pro-
fessional develops either positive or negative intentions
about the intervention. In the subsequent implementation
phase, the professional tries the new strategy and finds out
what working with the new strategy means. In the fourth
and final stage, the continuation stage, the new strategy be-
comes part of routine practice or it does not [37]. In this
RCT on the Coach2Move strategy, we work with GPTs who
have volunteered to participate in this trial and who are will-
ing to change their professional behavior. They did not,
however, have the opportunity to ‘practice’ with the Coach2-
Move strategy before the trial started. Also, willingness to
change on the personal level does not mean that the
organization (a physiotherapy practice) fully supports imple-
mentation of a new strategy. We have tried to improve ad-
herence to the Coach2Move strategy by developing an
electronic patient file that supports the GPT in executing
the strategy. In addition, the treatment given to each patient
in the intervention group is continuously evaluated by one
of the researchers (NV), and the GPTs are coached in work-
ing according to the Coach2Move strategy. However, when
the RCT has ended we still need to consider whether or not
implementation has been sufficient. We will use quality indi-
cators and process analysis to do this.
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